MDS patient characteristics
Case no. . | Age . | Sex . | MDS type . | Karyotype . | WBC (×1000/µl) . | ANC (×1000/µl) . |
---|---|---|---|---|---|---|
1-15 | Age-adjusted controls | |||||
16 | 79 | m | MDS del(5q) | 47,XY, del(5)(q11q33),+21 | 9,9 | 7,7 |
17 | 77 | f | RCMD | 46,XX | 1,3 | 0,5 |
18 | 72 | f | RAEB I | 46,X,idic(X)(q13)[16]/ 46, XX[13] | 4,3 | 1,9 |
19 | 69 | m | RCMD RS | 46, XY | 3,5 | 2,2 |
20 | 79 | m | RCMD | 46,XY,del(11)(q21)[6]/ 46,XY,del(9)(q22)[4]| 46,XY[18] | 3,3 | 2,1 |
21 | 71 | f | RARS | 46,XX | 5,2 | 4,3 |
22 | 74 | m | RCMD | 46,XY | 6,2 | 3,3 |
23 | 71 | f | RAEB II | 46,XX | 2,7 | 0,3 |
24 | 79 | m | RAEB I | 46,XY | 3,4 | 1,5 |
25 | 75 | m | RCMD | 46,XY | 13,7 | 7,8 |
26 | 76 | m | RAEB II | 46,XY | 2,3 | 0,4 |
27 | 73 | f | RCMD | 46,XX,del(5)(q14q33)[4]/ 46,XX[13] | 2,3 | 0,9 |
Mean | 75 | m/f (7/5) | 4,8 | 2,7 |
Case no. . | Age . | Sex . | MDS type . | Karyotype . | WBC (×1000/µl) . | ANC (×1000/µl) . |
---|---|---|---|---|---|---|
1-15 | Age-adjusted controls | |||||
16 | 79 | m | MDS del(5q) | 47,XY, del(5)(q11q33),+21 | 9,9 | 7,7 |
17 | 77 | f | RCMD | 46,XX | 1,3 | 0,5 |
18 | 72 | f | RAEB I | 46,X,idic(X)(q13)[16]/ 46, XX[13] | 4,3 | 1,9 |
19 | 69 | m | RCMD RS | 46, XY | 3,5 | 2,2 |
20 | 79 | m | RCMD | 46,XY,del(11)(q21)[6]/ 46,XY,del(9)(q22)[4]| 46,XY[18] | 3,3 | 2,1 |
21 | 71 | f | RARS | 46,XX | 5,2 | 4,3 |
22 | 74 | m | RCMD | 46,XY | 6,2 | 3,3 |
23 | 71 | f | RAEB II | 46,XX | 2,7 | 0,3 |
24 | 79 | m | RAEB I | 46,XY | 3,4 | 1,5 |
25 | 75 | m | RCMD | 46,XY | 13,7 | 7,8 |
26 | 76 | m | RAEB II | 46,XY | 2,3 | 0,4 |
27 | 73 | f | RCMD | 46,XX,del(5)(q14q33)[4]/ 46,XX[13] | 2,3 | 0,9 |
Mean | 75 | m/f (7/5) | 4,8 | 2,7 |
f, female; M, male; MDS del 5q, MDS with deletion of chromosome 5q as sole cytogenetic anomaly; RAEB I, refractory anemia with excess of blasts <10%; RAEB II, RAEB with ≥10% blasts; RARS, refractory anemia with ring sideroblasts; RCMD, refractory cytopenia with multilineage dysplasia; RCMD-RS, RCMD with ring siderolblasts.